1. Home
  2. LSTA vs FLUX Comparison

LSTA vs FLUX Comparison

Compare LSTA & FLUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • FLUX
  • Stock Information
  • Founded
  • LSTA 1980
  • FLUX N/A
  • Country
  • LSTA United States
  • FLUX United States
  • Employees
  • LSTA N/A
  • FLUX N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • FLUX Industrial Machinery/Components
  • Sector
  • LSTA Health Care
  • FLUX Miscellaneous
  • Exchange
  • LSTA Nasdaq
  • FLUX Nasdaq
  • Market Cap
  • LSTA 20.9M
  • FLUX 26.9M
  • IPO Year
  • LSTA N/A
  • FLUX N/A
  • Fundamental
  • Price
  • LSTA $2.75
  • FLUX $1.97
  • Analyst Decision
  • LSTA Strong Buy
  • FLUX Strong Buy
  • Analyst Count
  • LSTA 1
  • FLUX 2
  • Target Price
  • LSTA $15.00
  • FLUX $6.00
  • AVG Volume (30 Days)
  • LSTA 15.1K
  • FLUX 74.8K
  • Earning Date
  • LSTA 08-11-2025
  • FLUX 08-15-2025
  • Dividend Yield
  • LSTA N/A
  • FLUX N/A
  • EPS Growth
  • LSTA N/A
  • FLUX N/A
  • EPS
  • LSTA N/A
  • FLUX N/A
  • Revenue
  • LSTA $1,000,000.00
  • FLUX $63,074,000.00
  • Revenue This Year
  • LSTA N/A
  • FLUX $11.10
  • Revenue Next Year
  • LSTA N/A
  • FLUX $12.66
  • P/E Ratio
  • LSTA N/A
  • FLUX N/A
  • Revenue Growth
  • LSTA N/A
  • FLUX N/A
  • 52 Week Low
  • LSTA $1.87
  • FLUX $1.15
  • 52 Week High
  • LSTA $4.20
  • FLUX $4.75
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 54.52
  • FLUX 64.88
  • Support Level
  • LSTA $2.36
  • FLUX $1.36
  • Resistance Level
  • LSTA $3.07
  • FLUX $1.60
  • Average True Range (ATR)
  • LSTA 0.22
  • FLUX 0.13
  • MACD
  • LSTA 0.02
  • FLUX 0.04
  • Stochastic Oscillator
  • LSTA 51.39
  • FLUX 91.10

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

About FLUX Flux Power Holdings Inc.

Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications. It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.

Share on Social Networks: